Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;16(2):105-115.
doi: 10.1111/crj.13457. Epub 2021 Nov 9.

Serum tumor necrosis factor-α, interleukin-1β, interleukin-6, and interleukin-17 relate to anxiety and depression risks to some extent in non-small cell lung cancer survivor

Meifang Liu  1 , Yao Li  2 , Xuesong Liu  3
Affiliations

Serum tumor necrosis factor-α, interleukin-1β, interleukin-6, and interleukin-17 relate to anxiety and depression risks to some extent in non-small cell lung cancer survivor

Meifang Liu et al. Clin Respir J. 2022 Feb.

Abstract

Introduction: Inflammatory cytokines are proposed as modulators for the pathogenesis of anxiety and depression (anxiety/depression), and anxiety/depression are frequently existed in non-small cell lung cancer (NSCLC) survivors. However, no published study has explored the association of inflammation cytokines with anxiety/depression in NSCLC survivors.

Objectives: We aimed to evaluate serum tumor necrosis factor-α (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-17 (IL-17) levels, and their correlations with anxiety/depression in NSCLC survivors.

Methods: Totally, 217 NSCLC survivors and 200 controls were recruited. Then, inflammatory cytokines in serum samples were detected by enzyme-linked immunosorbent assay (ELISA). Besides, their anxiety/depression status was assessed by Hospital Anxiety and Depression Scale (HADS).

Results: HADS-anxiety score, anxiety rate, anxiety severity, HADS-depression score, depression rate, and depression severity were all increased in NSCLC survivors compared with controls (all P < 0.001). Regarding inflammatory cytokines, TNF-α, IL-1β, and IL-17 levels were higher (all P < 0.01), while IL-6 (P = 0.105) level was of no difference in NSCLC survivors compared with controls. Furthermore, TNF-α, IL-1β, IL-6, and IL-17 were all positively associated with HADS-A score (all P < 0.05), anxiety occurrence (all P < 0.05), HADS-D score (all P < 0.05), and depression occurrence (all P < 0.05) in NSCLC survivors, while the correlation-coefficients were weak. Additionally, multivariate logistic regression analyses disclosed that TNF-α (both P < 0.05) and IL-1β (both P < 0.001) were independently correlated with increased anxiety and depression risks in NSCLC survivors.

Conclusion: Serum TNF-α, IL-1β, IL-6, and IL-17 are related to increased anxiety and depression risks to some extent in NSCLC survivors.

Keywords: anxiety; depression; interleukin-1β; non-small cell lung cancer; tumor necrosis factor-α.

PubMed Disclaimer

Conflict of interest statement

The authors declared that they have no conflict of interest with the contents of this article.

Figures

FIGURE 1
FIGURE 1
Difference in anxiety and depression between controls and NSCLC survivors. Comparisons of HADS‐A score (A), anxiety rate (B), anxiety severity (C), HADS‐D score (D), depression rate (E), and depression severity (F) between controls and NSCLC survivors. HADS‐A, Hospital Anxiety and Depression Scale for anxiety; HADS‐D, Hospital Anxiety and Depression Scale for depressionNSCLC, non‐small cell lung cancer
FIGURE 2
FIGURE 2
Difference in TNF‐α, IL‐1β, IL‐6, and IL‐17 between controls and NSCLC survivors. Comparisons of serum TNF‐α (A), IL‐1β (B), IL‐6 (C), and IL‐17 (D) between controls and NSCLC survivors. IL‐1β, interleukin‐1β; IL‐6, interleukin‐6; IL‐17, interleukin‐17; NSCLC, non‐small cell lung cancer; TNF‐α, tumor necrosis factor‐α
FIGURE 3
FIGURE 3
Correlations of TNF‐α, IL‐1β, IL‐6, and IL‐17 with anxiety in NSCLC survivors. Correlations of serum TNF‐α (A), IL‐1β (B), IL‐6 (C), and IL‐17 (D) levels with HADS‐A score. Comparisons of serum TNF‐α (E), IL‐1β (F), IL‐6 (G), and IL‐17 (H) levels between anxiety NSCLC survivors and non‐anxiety NSCLC survivors. IL‐1β, interleukin‐1β; IL‐6, interleukin‐6; IL‐17, interleukin‐17; NSCLC, non‐small cell lung cancer; TNF‐α, tumor necrosis factor‐α
FIGURE 4
FIGURE 4
Correlations of TNF‐α, IL‐1β, IL‐6, and IL‐17 with depression in NSCLC survivors. Correlations of serum TNF‐α (A), IL‐1β (B), IL‐6 (C), and IL‐17 (D) levels with HADS‐D score. Comparisons of serum TNF‐α (E), IL‐1β (F), IL‐6 (G), and IL‐17 (H) levels between depression NSCLC survivors and non‐depression NSCLC survivors. IL‐1β, interleukin‐1β; IL‐6, interleukin‐6; IL‐17, interleukin‐17; NSCLC, non‐small cell lung cancer; TNF‐α, tumor necrosis factor‐α
See this image and copyright information in PMC

References

    1. Herbst RS, Morgensztern D, Boshoff C. The biology and management of non‐small cell lung cancer. Nature. 2018;553(7689):446‐454. - PubMed
    1. Henshall C, Davey Z. Development of an app for lung cancer survivors (iEXHALE) to increase exercise activity and improve symptoms of fatigue, breathlessness and depression. Psychooncology. 2020;29(1):139‐147. - PubMed
    1. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3(1):46‐52. - PubMed
    1. Jankowska‐Polanska B, Polanski J, Chabowski M, Rosinczuk J, Mazur G. Influence of coping strategy on perception of anxiety and depression in patients with non‐small cell lung cancer. Adv Exp Med Biol. 2020;1251:57‐70. - PubMed
    1. Hung MS, Chen IC, Lee CP, et al. Incidence and risk factors of depression after diagnosis of lung cancer: a nationwide population‐based study. Medicine (Baltimore). 2017;96(19):e6864. 10.1097/MD.0000000000006864 - DOI - PMC - PubMed

MeSH terms